| German V Crisostomo, MD | |
|
173 Chelsea St, Everett, MA 02149-4632 | |
| (781) 388-6200 | |
| (617) 387-9768 |
| Full Name | German V Crisostomo |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 36 Years |
| Location | 173 Chelsea St, Everett, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285749945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 77706 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cambridge Health Alliance | Cambridge, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eliot Community Human Services | 2062488000 | 69 |
News Archive
Bruker Corporation today announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed. For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker's revenue and to be accretive to EPS by about $0.01.
Jennerex, Inc., a clinical-stage biotherapeutics company developing a proprietary breakthrough class of targeted oncolytic virus therapeutics, today announced in conjunction with Lee's Pharmaceutical Holdings, the execution of a collaboration and license agreement for Jennerex's lead product candidate, JX-594, in certain Asian territories.
Rodents infected with a common parasite lose their fear of cats, resulting in easy meals for the felines. Now IU School of Medicine researchers have identified a new way the parasite may modify brain cells, possibly helping explain changes in the behavior of mice - and humans.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
A new study has found that men who inherit a rare genetic mutation are 10 to 20 times more likely than average to develop prostate cancer. The gene variant may help explain cases of the disease that run in families and strike men at unusually young ages.
› Verified 3 days ago
| Entity Name | Eliot Community Human Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679648182 PECOS PAC ID: 2062488000 Enrollment ID: O20040909001199 |
News Archive
Bruker Corporation today announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed. For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker's revenue and to be accretive to EPS by about $0.01.
Jennerex, Inc., a clinical-stage biotherapeutics company developing a proprietary breakthrough class of targeted oncolytic virus therapeutics, today announced in conjunction with Lee's Pharmaceutical Holdings, the execution of a collaboration and license agreement for Jennerex's lead product candidate, JX-594, in certain Asian territories.
Rodents infected with a common parasite lose their fear of cats, resulting in easy meals for the felines. Now IU School of Medicine researchers have identified a new way the parasite may modify brain cells, possibly helping explain changes in the behavior of mice - and humans.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
A new study has found that men who inherit a rare genetic mutation are 10 to 20 times more likely than average to develop prostate cancer. The gene variant may help explain cases of the disease that run in families and strike men at unusually young ages.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| German V Crisostomo, MD 173 Chelsea St, Everett, MA 02149-4632 Ph: (781) 388-6200 | German V Crisostomo, MD 173 Chelsea St, Everett, MA 02149-4632 Ph: (781) 388-6200 |
News Archive
Bruker Corporation today announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed. For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker's revenue and to be accretive to EPS by about $0.01.
Jennerex, Inc., a clinical-stage biotherapeutics company developing a proprietary breakthrough class of targeted oncolytic virus therapeutics, today announced in conjunction with Lee's Pharmaceutical Holdings, the execution of a collaboration and license agreement for Jennerex's lead product candidate, JX-594, in certain Asian territories.
Rodents infected with a common parasite lose their fear of cats, resulting in easy meals for the felines. Now IU School of Medicine researchers have identified a new way the parasite may modify brain cells, possibly helping explain changes in the behavior of mice - and humans.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
A new study has found that men who inherit a rare genetic mutation are 10 to 20 times more likely than average to develop prostate cancer. The gene variant may help explain cases of the disease that run in families and strike men at unusually young ages.
› Verified 3 days ago
Dr. Zainab Susan Jabur, MD, MPH Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 103 Garland St, Whidden Hospital, Everett, MA 02149 Phone: 617-381-7261 | |
Dr. Stephen Pinals, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 103 Garland St, Everett, MA 02149 Phone: 617-591-6413 | |
Jason B Strauss, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 103 Garland St, Gpsu, Lewis 2, Everett, MA 02149 Phone: 617-394-7696 Fax: 617-493-7725 | |
Dr. Ralph E Talbot, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 391 Broadway, Suite 304, Everett, MA 02149 Phone: 617-381-0555 Fax: 949-955-7321 | |
Roger L Greiger, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 173 Chelsea St, Everett, MA 02149 Phone: 781-388-6206 | |
Stephanie Shobha Mokashi, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 173 Chelsea St # Ma02149, Everett, MA 02149 Phone: 781-428-3800 |